首页|New Machine Learning Findings Reported from National Institute of Pharmaceutical Education and Research (Improved Qsar Models for Parp-1 Inhibition Using Data B alancing, Interpretable Machine Learning, and Matched Molecular Pair Analysis)
New Machine Learning Findings Reported from National Institute of Pharmaceutical Education and Research (Improved Qsar Models for Parp-1 Inhibition Using Data B alancing, Interpretable Machine Learning, and Matched Molecular Pair Analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
Springer Nature
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – Current study results on Machine Learn ing have been published. According to news reporting out of Assam, India, by New sRx editors, research stated, “The poly (ADP-ribose) polymerase-1 (PARP-1) enzym e is an important target in the treatment of breast cancer. Currently, treatment options include the drugs Olaparib, Niraparib, Rucaparib, and Talazoparib; howe ver, these drugs can cause severe side effects including hematological toxicity and cardiotoxicity.”
AssamIndiaAsiaCyborgsEmerging Te chnologiesMachine LearningNational Institute of Pharmaceutical Education and Research
NETL
NSTL
Springer Nature
